Citation: Bj. Weigel et al., Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma, J PED H ONC, 23(5), 2001, pp. 272-276
Authors:
Breitfeld, PP
Lyden, E
Raney, RB
Teot, LA
Wharam, M
Lobe, T
Crist, WM
Maurer, HM
Donaldson, SS
Ruymann, FB
Citation: Pp. Breitfeld et al., Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the Intergroup Rhabdomyosarcoma Study Group, J PED H ONC, 23(4), 2001, pp. 225-233
Authors:
Breitfeld, PP
Dale, T
Kohne, J
Hui, S
Tierney, WM
Citation: Pp. Breitfeld et al., Accurate case finding using linked electronic clinical and administrative data at a children's hospital, J CLIN EPID, 54(10), 2001, pp. 1037-1045
Authors:
Breitfeld, PP
Weisburd, M
Overhage, JM
Sledge, G
Tierney, WM
Citation: Pp. Breitfeld et al., Pilot study of a point-of-use decision support tool for cancer clinical trials eligibility, J AM MED IN, 6(6), 1999, pp. 466-477
Authors:
Pappo, AS
Anderson, JR
Crist, WM
Wharam, MD
Breitfeld, PP
Hawkins, D
Raney, RB
Womer, RB
Parham, DM
Qualman, SJ
Grier, HE
Citation: As. Pappo et al., Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group, J CL ONCOL, 17(11), 1999, pp. 3487-3493